CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-06 | Schorno Dean L EVP &Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-02-06 | RODRIGUEZ RAUL R CEO, President | Grant or award · Stock Option (right to buy) | +650,000 | 650,000 | ||
| 2019-11-18 | Schorno Dean L EVP &Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +83,750 | 83,750 | ||
| 2019-11-18 | Lasaga Joseph Sr.VP Bus.Dev.Alliance Mgmt. | Grant or award · Employee Stock Option (right to buy) | +43,750 | 43,750 | ||
| 2019-11-18 | Masuda Esteban Sr. VP Research | Sale · Employee Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2019-11-18 | Mayer Eldon C. III EVP & Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-11-18 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-11-18 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +237,500 | 237,500 | ||
| 2019-11-18 | Dummer Wolfgang EVP & CMO | Grant or award · Employee Stock Option (right to buy) | +220,000 | 220,000 | ||
| 2019-05-23 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-05-23 | Goodwin Bradford S Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-05-23 | Kotzin Brian L. Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-05-23 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +13,750 | 13,750 | ||
| 2019-05-23 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-05-23 | LYONS GARY A Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-05-23 | MOOS WALTER H Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2019-05-22 | Schorno Dean L EVP &Chief Financial Officer | Purchase | +46,726 | $2.13 | $100K | 46,726 |
| 2019-05-22 | Schorno Dean L EVP &Chief Financial Officer | Purchase | +3,274 | $2.13 | $7K | 50,000 |
| 2019-04-01 | Wasman Jane Director | Grant or award · Stock Option ( Right to Buy) | +80,000 | 80,000 | ||
| 2019-03-20 | Schorno Dean L EVP &Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +83,750 | 83,750 |
Page 14 of 16 · 310 trades